Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cryo Cell International (CCEL) Other Non Operating Income (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Other Non Operating Income for 13 consecutive years, with -$34562.0 as the latest value for Q4 2025.

  • On a quarterly basis, Other Non Operating Income fell 133.01% to -$34562.0 in Q4 2025 year-over-year; TTM through Aug 2025 was $139268.0, a 115.8% increase, with the full-year FY2024 number at $105887.0, down 13.29% from a year prior.
  • Other Non Operating Income was -$34562.0 for Q4 2025 at Cryo Cell International, down from $17565.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $383365.0 in Q4 2022 to a low of -$223974.0 in Q2 2023.
  • A 5-year average of $39664.6 and a median of $137.0 in 2024 define the central range for Other Non Operating Income.
  • Peak YoY movement for Other Non Operating Income: skyrocketed 782277.55% in 2022, then tumbled 189908.47% in 2023.
  • Cryo Cell International's Other Non Operating Income stood at $49.0 in 2021, then surged by 782277.55% to $383365.0 in 2022, then tumbled by 83.47% to $63356.0 in 2023, then skyrocketed by 65.27% to $104706.0 in 2024, then plummeted by 133.01% to -$34562.0 in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Other Non Operating Income are -$34562.0 (Q4 2025), $17565.0 (Q3 2025), and $16997.0 (Q2 2025).